HealthNovember 08, 2017

Webinar: CriticalPoint's 2017 USP study results: Why don't we embrace better practice?

Compounding experts review the results of the seventh annual Critical Point USP 797 Compliance Study. Are we as safe as an industry as we should be?

Ever since a series of widely reported sterile compounding incidents involving patient harm and death, hospital pharmacies have been under much closer scrutiny by regulatory and licensing agencies for compliance with USP 797, but has the industry response been as thorough as it needs to be?

Join us for this webinar unveiling the results of the seventh annual Critical Point USP 797 Compliance Study. Kate Douglass, MS, RN, CRNI and Eric Kastango, RPh, MBA, unveil the data, explore how it compares to previous years, and explain what it means for sterile compounding safety going forward.

Access the on-demand webinar

Solutions
Simplifi 797®

Take the guesswork out of USP medication compounding compliance with a customizable, mobile, evidence-based solution.

 

Simplifi 797 provides the latest evidence-based guidance and helps navigate the complex USP Chapters 795, 797 and 800 processes to ensure inspection confidence and keep patients and staff safe.